MsbA inhibitor 1

CAS No. 52535-76-9

MsbA inhibitor 1( —— )

Catalog No. M14858 CAS No. 52535-76-9

MsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 1008 Get Quote
100MG 1602 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MsbA inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    MsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor.
  • Description
    MsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor, inhibits MsbA, an ATP-dependent flippase that translocates LPS across the inner membrane; causes mislocalization of LPS to the cell interior, inhibits Δ5 strain with MIC of 0.2 ug/ml.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    52535-76-9
  • Formula Weight
    335.802
  • Molecular Formula
    C16H14ClNO3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (372.23 mM)
  • SMILES
    ——
  • Chemical Name
    2-(4-chlorobenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang G, et al. Proc Natl Acad Sci U S A. 2018 May 7. pii: 201804670.
molnova catalog
related products
  • Rifamycin sodium sal...

    Rifamycin is an antibiotic that inhibits bacterial DNA-dependent RNA polymerase. It is effective against Gram-positive bacteria.

  • Heraclenol

    Heraclenol is derived from the fruits of Angelica lucida with antibacterial activities. Heraclenol is a germination inhibitor in the parsley and lettuce seeds.

  • Gatifloxacin mesylat...

    A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.